Investment
Features
FeesSafety
Academy
More
Pluang+

Compare abrdn Income Credit Strategies Fund (ACP) vs Cigna Corp (CI) Price & Performance

abrdn Income Credit Strategies FundTrade
Cigna CorpTrade

Price performance (Past 24H)

Key statistics

abrdn Income Credit Strategies Fund vs Cigna Corp — how do they compare? abrdn Income Credit Strategies Fund trades at $5.11 (market cap $637.39M), while Cigna Corp trades at $272.72 (market cap $73.56B). The key difference: Cigna Corp is far larger — about 115.4× abrdn Income Credit Strategies Fund's market cap, and abrdn Income Credit Strategies Fund pays the higher dividend (18.31%). Which is the better fit depends on your goals.

ACPCI
Market Cap
$637.39M$73.56B
Sector
FinancialsHealth
52-Week High
$5.98$311.00
52-Week Low
$5.01$244.41
Dividend Yield
18.31%2.24%
Enterprise Value
$98.27B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

abrdn Income Credit Strategies Fund

ACP trades at $5.08, up 0.4% today, with a bearish technical signal from moving averages and a neutral stance from oscillators. The stock shows a low P/E of 7.7 and P/B of 0.9, indicating potential undervaluation, while net income margin remains high at 95.31%. Recent news highlights dividend declarations but also concerns over distribution sustainability from Seeking Alpha (2026-05-29).

The outlook is mixed: attractive valuation and dividends offer income appeal, but technical weakness and high distribution reliance pose risks. Investors should weigh the fund's high yield against credit spread tightness and leverage exposure noted in analyst reports.

Cigna Corp

Cigna (CI) trades at $282.49, up 2.63% with strong earnings beats in recent quarters. The stock shows bearish technical signals but benefits from low valuation ratios like a P/E of 11.68 and P/S of 0.27. Recent Q2 2026 results exceeded expectations, with EPS of $7.78 beating estimates, and the company raised its full-year guidance to at least $30.45 adjusted EPS, reflecting robust growth in health services and insurance segments.

The outlook is positive due to consistent earnings outperformance and raised guidance, though technical weakness and competitive pressures pose risks. Analyst consensus is strongly bullish with a $338.90 price target, indicating ~20% upside potential from current levels, supported by dividend payments and institutional accumulation.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About abrdn Income Credit Strategies Fund

abrdn Income Credit Strategies Fund is a diversified, closed-end investment management company. Its primary goal is to generate high current income, with capital appreciation as a secondary objective. The fund mainly invests in debt and loan instruments from issuers across various industries and regions.

Read more on ACP

About Cigna Corp

Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM services were greatly expanded by its 2018 merger with Express Scripts and are mostly sold to health insurance plans and employers. Its largest PBM contract is the Department of Defense. In health insurance and other benefits, Cigna mostly serves employers through self-funding arrangements, but it also operates in government programs, such as Medicare Advantage. The company operates mostly in the U.S. with 15 million medical members covered as of the end of 2020, but its services extend internationally, covering another 2 million people.

Read more on CI